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Phosphatidylethanolamine 
dynamics are required for 
osteoclast fusion
Atsushi Irie1, Kei Yamamoto1,2,3, Yoshimi Miki1 & Makoto Murakami1,4
Osteoclasts, responsible for bone resorption, are multinucleated cells formed by cell-cell fusion of 
mononuclear pre-osteoclasts. Although osteoclast fusion is a pivotal step for osteoclastogenesis, 
little is known about the mechanism involved. To clarify the underlying process, we investigated 
dynamics of membrane phospholipids during osteoclastogenesis in vitro. We found that the cellular 
content of phospholipids, phosphatidylethanolamine (PE) in particular, was increased during 
osteoclast differentiation. Furthermore, PE was greatly increased in the outer leaflet of the plasma 
membrane bilayer during osteoclastogenesis, being concentrated in filopodia involved in cell-cell 
fusion. Immobilisation of the cell surface PE blocked osteoclast fusion, revealing the importance of PE 
abundance and distribution. To identify the molecules responsible for these PE dynamics, we screened a 
wide array of lipid-related genes by quantitative PCR and shRNA-mediated knockdown. Among them, 
a PE-biosynthetic enzyme, acyl-CoA:lysophosphatidylethanolamine acyltransferase 2 (LPEAT2), and 
two ATP-binding cassette (ABC) transporters, ABCB4 and ABCG1, were markedly increased during 
osteoclastogenesis, and their knockdown in pre-osteoclasts led to reduction in PE exposure on the 
cell surface and subsequent osteoclast fusion. These findings demonstrate that the PE dynamics 
play an essential role in osteoclast fusion, in which LPEAT2, ABCB4 and ABCG1 are key players for PE 
biosynthesis and redistribution.
Bone metabolism involves a continuous process of remodelling that is maintained as a strictly coupled balance 
between bone formation by osteoblasts and bone resorption by osteoclasts. Osteoclasts are multinucleated cells 
derived from hematopoietic precursors of the monocyte/macrophage lineage. The hematopoietic precursors 
differentiate into mononucleated pre-osteoclasts upon stimulation with macrophage colony-stimulating factor 
(M-CSF) and receptor activator of nuclear factor-κ B ligand (RANKL), which are essential for osteoclast differen-
tiation1. At a late stage of osteoclast differentiation, mononucleated pre-osteoclasts undergo cell-cell fusion with 
one another to form multinucleated mature osteoclasts.
Recent studies have identified particular molecules that are involved in osteoclast fusion. Dendritic 
cell-specific transmembrane protein (DC-STAMP) is required for multinucleation of osteoclasts2. In addition, 
vacuolar (H+) ATPase (v-ATPase), E-cadherin, a disintegrin and metalloproteinase domain-containing protein 
(ADAM)8, ADAM12, CD9, CD44, CD47 and osteoclast stimulatory transmembrane protein have also been 
implicated in osteoclast fusion3. However, the molecular mechanisms whereby these molecules facilitate osteo-
clast fusion are still obscure.
Cell-cell fusion is a process critical for development and maintenance of several tissues, including fertilisation, 
myoblast fusion, macrophage giant cell formation and osteoclastogenesis4. The process of cell fusion consists of 
sequential steps: First, cells recognise their fusing partner cells, and then phospholipid bilayers in the cellular 
plasma membrane come into contact with each other, followed by formation of a hemifusion intermediate struc-
ture in which the outer leaflets of apposed membranes merge while the inner leaflets remain distinct. This inter-
mediate conformation then breaks and a fusion pore is formed, the latter finally expanding to complete the fusion 
process5. Thus, during cell-cell fusion, the structure of the lipid bilayers undergoes dynamic change, whereby the 
stability and fluidity of the bilayers are altered.
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Phospholipids are the most fundamental components of the lipid bilayer in cell membranes. They are clas-
sified into several groups based on their hydrophilic head groups, which include phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI) and sphingomyelin (SM). 
Phospholipids can be biosynthesised via different pathways: the major route for phospholipid biosynthesis is a 
de novo pathway, in which the head groups of phospholipids are transferred to diacylglycerol6. Phospholipids are 
also remodelled through rapid turnover of fatty acyl chains through deacylation by phospholipases and reac-
ylation by acyl-CoA-dependent lysophospholipid acyltransferases (LPLATs)7,8. In addition, PE is synthesised 
through decarboxylation of PS catalysed by PS decarboxylase9. Although the phospholipid compositions and 
distributions in biological membranes vary among animal species, cell types and intracellular organelles, phos-
pholipids are distributed asymmetrically in the plasma membrane of most mammalian cells; PC/SM and PE/PS/
PI are localised in the outer and inner leaflets, respectively10. Three functional groups of lipid transporters distrib-
uted across the outer and the inner leaflets of the lipid bilayer regulate this asymmetric distribution of phospho-
lipids. Flippases, which include the P-type ATPase superfamily, constitute the first group, transporting lipids from 
the outer to the inner leaflet11. Floppases, constituting the second group, transport lipids from the inner to the 
outer leaflet, and this activity is attributed to ATP-binding cassette (ABC) transporters11. The third group of lipid 
transporters, called scramblases, mobilises lipids bidirectionally between the outer and inner leaflets, and include 
the anoctamin (also known as transmembrane protein (TMEM) 16) and Xk-related (Xkr) protein families12.
Since the head group of PE is smaller than those of other phospholipids, PE prefers the concave volume of the 
inner leaflet of the lipid bilayer13, and the localisation of PE in the inner plasma membrane stabilises the mor-
phology of cells. However, PE translocates to the outer leaflet at the cleavage furrow when cells divide14. Moreover, 
biophysical studies have shown that PE-rich liposomes promote formation of the hemifusion intermediate struc-
ture during membrane fusion15. These observations suggest that PE is dynamically redistributed within the lipid 
bilayer, leading to changes in membrane curvature and thereby the morphology of cells. In addition to the head 
groups, the hydrophobic fatty acid tails of phospholipids also affect the characteristics of membranes. Unsaturated 
fatty acids have kinked carbohydrate chains, which interfere with the highly ordered packing of membranes, and 
therefore phospholipids containing unsaturated fatty acids reduce the stability of the membrane and increase its 
fluidity16.
Although phospholipids are the principal components of cellular membranes and are expected to be key 
players in cell-cell fusion, their compositions and distributions during the process of cell fusion, including that 
in osteoclastogenesis, have been poorly characterised. Here we have investigated the dynamics of phospholipids 
during osteoclastogenesis and provide the first evidence that redistribution of PE in the plasma membrane is 
essential for osteoclast fusion.
Results
Increase of the proportion of PE during osteoclastogenesis. Osteoclast precursors were generated 
from mouse bone marrow cells by culture with M-CSF and transforming growth factor (TGF)-β and differen-
tiated into multinucleated mature osteoclasts expressing tartrate-resistant acid phosphatase (TRAP), a marker 
enzyme for osteoclast differentiation17, by culture with RANKL and M-CSF in vitro. Accordingly, although no 
TRAP-positive multinucleated cells were observed after treatment with RANKL and M-CSF for 1 day (Fig. 1A), 
TRAP-positive multinucleated cells began to appear after culture with RANKL and M-CSF for 2 days, and most 
of these cells became fused, giving rise to multinucleated osteoclasts, on days 3–4 (Fig. 1A). To investigate phos-
pholipids during osteoclastogenesis, we extracted them from undifferentiated and differentiated osteoclasts and 
analysed their compositions. Total phospholipid contents in the cells were 11.21 ± 1.63 and 50.60 ± 5.58 nmol/
well on day 1 and day 3, respectively, revealing an approximately 4~5-fold increase after osteoclast differentiation 
and fusion. Although the compositions of PC, PI and PS relative to total phospholipids were not significantly 
changed, the ratio of PE in differentiated cells was significantly higher than that in undifferentiated cells, accom-
panied by a trend toward reciprocal reduction of the ratio of SM (Fig. 1B).
To further assess the alterations of phospholipids, we performed mass spectrometry (MS)-based lipidomics 
using undifferentiated and differentiated osteoclasts. Representative MS patterns of total PC and PE extracted 
from cells cultured in a 96-well plate are shown in Fig. 1C, where most PC and PE species were increased after 
differentiation. A notable difference between these two phospholipids was that saturated and monounsaturated 
fatty acids were abundant in the sn-2 position of PC, whereas that of PE was enriched in polyunsaturated fatty 
acids, including arachidonic acid (C20:4) and docosahexaenoic acid (DHA, C22:6) (Fig. 1C). Quantification of 
individual phospholipid species confirmed the increases of most PC (2~3-fold) and PE (3~10-fold) species in the 
differentiated cells (Fig. 1D,E). These results suggest that the biosynthesis of phospholipids, particularly PE with 
polyunsaturated fatty acids, is elevated during osteoclast differentiation.
Increase of cell surface PE during osteoclast differentiation. To address the distribution of PE dur-
ing osteoclastogenesis, we visualised PE in the osteoclast membrane using Ro09–0198, a tetracyclic polypeptide 
that binds specifically to PE18, conjugated with streptavidin-biotin (SA-Bio-Ro). Since SA-Bio-Ro has no mem-
brane permeability, it has been used as a convenient probe for detection of PE residing in the outer, but not inner, 
leaflet of the plasma membrane14. When osteoclast precursors were cultured with RANKL and M-CSF for 1 day, 
or with M-CSF in the absence of RANKL for 3 days, the fluorescence signal for PE on the cell surface was rather 
faint (Fig. 2A). In sharp contrast, mature osteoclasts induced by RANKL and M-SCF for 3 days exhibited a robust 
fluorescence signal in outer edges of the cells (Fig. 2A). No fluorescence staining was observed with SA-Bio, a 
control conjugate, confirming that the prominent FITC staining with SA-Bio-Ro in mature osteoclasts is specific 
for binding of Ro09–0198 to the cell surface (Fig. 2A). These results suggest that PE is exposed on the outer leaflet 
of the plasma membrane during osteoclast maturation.
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Figure 1. Increase of PE content during osteoclastogenesis. (A) Osteoclast differentiation in vitro. Bone 
marrow cells were cultured with M-CSF and TGF-β for 3 days (osteoclast precursors) and then for an additional 
1 day (immature osteoclasts) or 3 days (mature osteoclasts) with RANKL and M-CSF. The cells were stained for 
TRAP. (B) Phospholipid compositions of immature and mature osteoclasts. Osteoclast precursors (6 × 105 cells/
well in 6-well plates) were cultured for 1 or 3 days with RANKL and M-CSF, and lipids extracted from these cells 
were separated by two-dimensional thin layer chromatography and quantified. The percentages of individual 
phospholipid species relative to total phospholipids are shown (n = 6). (C) Representative MS profiles of PC 
and PE species in immature and mature osteoclasts. Phospholipids extracted from the cells cultured in a 96-well 
plate were applied to the MS analysis. Peaks for major molecular species are indicated. (D) Quantitative results 
of MS analysis (n = 4). (E) Fold increase (day 3 versus day 1) of the individual phospholipid species quantified 
in (D) (n = 4). A dashed line (fold increase of 1) indicates that the amounts before and after differentiation are 
equivalent. Each value is the mean ± SE.
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In most mammalian cells, PS is localised preferentially in the inner leaflet of the plasma membrane and exter-
nalised to the outer leaflet during apoptosis19. The signal for annexin V, a PS-binding protein that detects exter-
nalised PS20, was barely evident in both undifferentiated and differentiated osteoclasts, even though prominent 
annexin V staining was obvious in osteoclasts undergoing apoptosis by treatment with alendronate21 (Fig. 2B). 
These results indicate that PE is specifically externalised on the plasma membrane of mature osteoclasts.
Prior to cell-cell fusion, osteoclast precursors protruded “neurite-like” filopodia and formed contacts with 
their neighbouring precursor cells (Fig. 3A). To obtain further details of PE localisation during osteoclastogen-
esis, we stained PE on the cell surface at the stages of osteoclast multinucleation. It was noteworthy that, in 
the earlier stage of multinucleation, PE was localised preferentially to the outer leaflet of filopodia in osteoclast 
precursors (Fig. 3B, Magnified #1, yellow arrows) and in cells contacted with each other via extended filopodia 
(Fig. 3B, Magnified #2, red arrows). Furthermore, multinucleated precursors in the later stage of osteoclast dif-
ferentiation were in contact with neighbouring precursors via a number of filopodia, and PE was concentrated 
on the surface of the filopodia (Fig. 3C, arrow). During the cell-cell fusion process, fusing cells adhere to their 
partner cells and then actin accumulates at the site of fusion22. When two osteoclasts were in the process of fusion, 
both actin and PE signals were distributed at foci of cell fusion (Fig. 3D, arrows), suggesting that PE was exposed 
at the cell surface actin foci. Thus, PE on the cell surface is preferentially localised to filopodia where cell-cell 
fusion takes place.
Cell surface PE is essential for osteoclast fusion. To examine whether the exposure of PE on the cell 
surface is functionally involved in osteoclast fusion, mononucleated osteoclast precursors were treated with 
SA-Bio-Ro, which immobilises cell surface PE in culture cells14. Notably, SA-Bio-Ro inhibited multinucleation of 
osteoclasts with an IC50 of 45 μ g/ml (Fig. 4A,B), whereas TRAP activity was insensitive at this concentration and 
blocked partially only at the highest concentration of 150 μ g/ml (Fig. 4C). Expression levels of a panel of genes 
encoding osteoclast differentiation markers, including nuclear factor of activated T cells (NFAT) c1, cathepsin 
K, v-ATPase V0 domain and DC-STAMP (encoded by Nfatc1, Ctsk, Atp6v0d2 and Dcstamp, respectively), were 
unaffected or decreased only modestly in cells treated with SA-Bio-Ro (Fig. 4D). These results suggest that the 
SA-Bio-Ro-treated cells still retained osteoclast signatures, but failed to become multinucleated. Thus, it appears 
that translocation of PE to the outer leaflet of the plasma membrane is essential for osteoclast fusion during 
osteoclastogenesis.
Screening of lipid-related molecules whose expressions are correlated with PE dynamics. To 
determine the molecules responsible for PE dynamics during osteoclastogenesis, we screened 130 molecules 
related to lipid (particularly PE) biosynthesis, lipid degradation and transbilayer lipid transport using quanti-
tative PCR. These included acyltransferases, phospholipid synthases, lipid phosphatases, phospholipases, ABC 
Figure 2. Increase of PE on the cell surface during osteoclast differentiation. Osteoclast precursors were 
cultured for 1 day or 3 days with M-CSF in the presence or absence of RANKL, and then exposure of PE 
(A) and PS (B) on the cell surface was assessed. (A) PE staining with SA-Bio-Ro. The cells were treated with 
cell-impermeable SA-Bio-Ro for 30 min and fixed. SA-Bio-Ro bound to the cell surface was stained with a 
FITC-conjugated anti-streptavidin antibody. DIC, difference interference contrast. For control, differentiated 
osteoclasts were treated with SA-Bio and immunostained. (B) PS staining with Cy5-conjugated annexin V. For 
positive control, differentiated osteoclasts (day 3) were cultured for an additional 1 day with 10 μ M alendronate 
to induce apoptosis.
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transporters, P-type ATPases and scramblases. Heat map visualisation (fold changes) of individual genes dur-
ing osteoclast differentiation and their precise expression levels in osteoclasts are summarised in Fig. 5 and 
Supplementary Figs 1 and 2, respectively. Among the molecules screened, we focused on several genes whose 
expression levels were high in osteoclasts and altered markedly during osteoclastogenesis. These genes were 
1-acylglycerol-3-phosphate O-acyltransferase 4 (AGPAT4; encoded by Agpat4), which transfers a fatty acyl res-
idue to lysophosphatidic acid to produce phosphatidic acid, a major precursor for PE as well as PC, PS and 
PI23; acyl-CoA:lysophosphatidylethanolamine acyltransferase 2 (LPEAT2; encoded by Lpeat2), a member of 
the LPLAT family implicated in PE biosynthesis24; CTP:phosphoethanolamine cytidylyltransferase 2 (PCYT2; 
encoded by Pcyt2), which catalyses the production of CDP-ethanolamine, a precursor of PE in the de novo bio-
synthetic pathway9; PS decarboxylase (encoded by Pisd), which converts PS to PE; ABCA2, ABCB4 and ABCG1 
(encoded by Abca2, Abcb4 and Abcg1, respectively), members of the ABC transporters implicated in outward 
translocation of phospholipids25; ATP8B4 (encoded by Atp8b4), a putative membrane flippase26, and anoc-
tamin 6 (Ano6, also known as TMEM16F; encoded by Ano6), a phospholipid scramblase27. All of these genes 
were expressed at high levels and prominently induced or downregulated during osteoclastogenesis (Fig. 5 and 
Supplementary Figs 1 and 2). To determine whether these lipid-related molecules are responsible for PE dynamics 
during osteoclastogenesis, we produced retroviruses that expressed shRNA-targeting mRNAs for these molecules, 
infected them into osteoclast precursors, and cultured the cells with RANKL and M-CSF for subsequent analysis.
LPEAT2 is responsible for PE biosynthesis and osteoclast formation. Among the lipid-biosynthetic 
or -degrading enzymes screened thus far, expression of Lpeat2 was relatively higher than that of others and 
markedly induced during osteoclastogenesis (Fig. 6A and Supplementary Fig. 1). The kinetic increase of Lpeat2 
expression occurred in parallel with that of PE proportion (Supplementary Fig. 3A), which preceded induction 
of osteoclast differentiation markers (Acp5 and Dcstamp) (Supplementary Fig. 3B), raising the possibility that 
LPEAT2 might be responsible for the increased PE production in the process of osteoclast differentiation. When 
Lpeat2 expression was silenced by retrovirus-mediated transfer of its specific shRNA (to 37% of control) (Fig. 6B), 
formation of TRAP-positive multinucleated osteoclasts was greatly inhibited (to 21% of control), even though 
the cells were still stained for TRAP (Fig. 6C,D). Another LPEAT2-directed shRNA also inhibited osteoclast 
Figure 3. Localisation of PE on the surface of fusing filopodia during osteoclastogenesis. (A) TRAP 
staining of pre-osteoclasts. Osteoclast precursors were cultured for 2 days with M-CSF and RANKL, and then 
stained for TRAP. The cells protruded long filopodia and formed contacts with neighbouring precursor cells. 
(B) Distribution of PE in osteoclast precursors in the earlier stage of multinucleation. Osteoclast precursors 
undergoing cell-cell fusion were treated with SA-Bio-Ro and immunostained. Areas in white boxes in the left 
panels are magnified in the right panels. A cell coloured in yellow (#1) extended several filopodia where PE was 
localised to their surface (yellow arrows in Magnified #1). Red and blue coloured cells (#2) contacted with each 
other via long filopodia. PE staining was observed on the surface of the protrusions (red arrow in Magnified 
#2). (C) Multinucleated cells in the later stage extended a number of filopodia and formed contacts with their 
neighbouring cells (white arrow). (D) Distribution of PE and actin at foci of cell fusion. SA-Bio-Ro-treated 
osteoclasts were immunostained for streptavidin (green) and actin (red). Areas in white boxes in the top panels 
are magnified in the bottom panels. Arrows point to the region of cell fusion.
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formation (Supplementary Fig. 3C,D), ruling out the possibility of an off-target effect. MS-based quantification 
of individual PC and PE species revealed that most PC species were reduced only modestly (to approximately 
70–80% of control), while most PE species showed greater reduction (to approximately 40–60% of control) by 
LPEAT2 knockdown (Fig. 6E,F), suggesting that LPEAT2 synthesises PE in preference to PC with no apparent 
selectivity for fatty acid incorporation in differentiating osteoclasts. Moreover, the inhibition of PE synthesis by 
LPEAT2 knockdown was accompanied by marked reduction of PE exposure on the cell surface (to 49% of con-
trol) during osteoclast formation (Fig. 6G,H). However, knockdown of LPEAT2 did not affect the expressions of 
Acp5 (encoding TRAP), Nfatc1, Ctsk, Atp6v0d2 and Dcstamp (Fig. 6I), reminiscent of the results of SA-Bio-Ro 
treatment, which did not affect the expressions of these genes for osteoclast differentiation and function (Fig. 4D). 
In contrast, shRNA knockdown of PCYT2 and PS decarboxylase failed to block osteoclast formation or PE expo-
sure on the cell surface (Supplementary Fig. 4), suggesting that these PE-biosynthetic enzymes are dispensable for 
the PE dynamics in osteoclasts. Although introduction of AGPAT4-targeted shRNA caused a slight inhibition of 
osteoclast formation, it did not affect the localisation of PE (Supplementary Fig. 4). Taken together, these results 
suggest that LPEAT2 is the major contributor to PE production that is linked to the increased PE exposure on the 
cell surface during osteoclastogenesis.
ABCB4 and ABCG1 are responsible for PE relocalisation and osteoclast formation. To deter-
mine the molecule(s) responsible for PE translocation to the cell surface during osteoclastogenesis, we next per-
formed shRNA knockdown analysis of lipid flip-flop proteins. Among these transporters, mRNA expressions 
of ABCB4 and ABCG1 were elevated (yet with different kinetics) during osteoclastogenesis (Fig. 7A), and their 
expression levels were relatively high compared to other ABC transporters (Supplementary Fig. 2). We noted 
that knockdown of either ABCB4 or ABCG1 resulted in marked reduction (to ~30% of control) of its expression 
(Fig. 7B), which was accompanied by modest but significant reduction of PE exposure on the cell surface (to 77% 
and 74% of control, respectively) (Fig. 7C). When both ABCB4 and ABCG1 were simultaneously silenced, the 
suppression of PE relocalisation was even more prominent (to 55% of control) (Fig. 7B,C). Importantly, these 
partial impairments of PE exposure on the cell surface in the knockdown cells resulted in greater reduction 
of the number of multinucleated osteoclasts formed (to 65%, 76% and 29% of control by silencing of ABCB4, 
ABCG1 and both, respectively) (Fig. 7D,E). Experiments using the second ABCB4- or ABCG1-directed shRNA 
also gave similar results (Supplementary Fig. 5A,B). Neither LPEAT2 expression nor PE abundance and compo-
sition was profoundly affected by double knockdown of ABCB4 and ABCG1(Supplementary Fig. 5C,D), further 
Figure 4. Blocking of osteoclast fusion by immobilisation of cell surface PE. Osteoclast precursors cultured 
for 2 days with RANKL and M-CSF were incubated with 100 μ g/ml (A) or various concentrations (B and C) of 
SA-Bio-Ro for 1 h, washed, and cultured for additional 1 day. (A) TRAP staining of SA-Bio-Ro-treated cells.  
(B) The number of TRAP-positive multinucleated osteoclasts (n = 4). (C) TRAP activity of SA-Bio-Ro-treated 
cells (n = 7). (D) Gene expressions of osteoclast differentiation markers. Osteoclast precursors (day 0) were 
cultured with M-CSF in the presence or absence of RANKL for 3 days with or without SA-Bio-Ro treatment 
(100 μ g/ml) on day 2. Total RNAs from the cells were reverse-transcribed and quantitative PCR for indicated 
genes was performed (n = 5 to 9). Each value is the mean ± SE.
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supporting that LPEAT2 and ABCB4/ABCG1 act on distinct steps of PE dynamics, i.e. its biosynthesis and trans-
port, respectively. On the other hand, the expressions of Acp5, Nfatc1, Ctsk, Atp6v0d2 and Dcstamp were unaf-
fected or changed only slightly by knockdown of these ABC transporters (Fig. 7F), suggesting that the reduction 
of ABCB4 or ABCG1 impairs only the cell-cell fusion process but does not affect cell differentiation per se during 
osteoclast formation. In contrast, shRNA knockdown of other lipid transporters, including ABCA2 (another 
potential floppase), ATP8B4 (a potential flippase whose downregulation could be linked to PE exposure) and 
Ano6 (a scramblase whose upregulation could be linked to PE exposure), affected neither osteoclast formation 
nor PE relocalisation on the cell surface (Supplementary Fig. 4), thus ruling out the possibility that they contrib-
uted to PE translocation. In conclusion, these results suggest that ABCB4 and ABCG1 are responsible for the 
translocation of PE to the external surface, which has profound influence on osteoclast formation, most likely 
cell-cell fusion, at the final stage of osteoclastogenesis.
Discussion
In this study, we have provided evidence that alteration in the asymmetric distribution of PE in the plasma mem-
brane is crucial for proper osteoclast homeostasis. During ex vivo osteoclastogenesis, PE, which otherwise resides 
in the inner leaflet of the plasma membrane, is highly exposed on the cell surface, particularly in filopodia, of 
osteoclasts undergoing cell-cell fusion. shRNA-based knockdown studies have revealed that the PE-biosynthetic 
enzyme LPEAT2 and the phospholipid floppases ABCB4 and ABCG1, which are markedly induced during oste-
oclastogenesis, lead to increased biosynthesis and mobilisation of PE and thereby promotion of cell-cell fusion.
Biological membranes exhibit various function-related shapes, and membrane curvature defines the morphol-
ogy of the plasma membrane and intracellular organelles13. Phospholipids have intrinsic head groups, which are 
critical determinants of membrane curvature depending on their structures. Both PC and SM have a larger cho-
line head group and tend to form convex structures when the lipids pack together. In contrast, PE has a smaller 
head group and packs into concave structures13. Therefore, in the plasma membrane of typical spheroidal cells, 
PC and SM tend to be localised in the outer leaflet to form a convex shape, whereas PE localises preferentially to 
the inner leaflet with a concave shape. Although PS is cylindrical and has no preferred curvature, this negatively 
Figure 5. Gene expression profiles of lipid-related molecules during osteoclastogenesis. Osteoclast 
precursors (day 0, control) were cultured with M-CSF and RANKL for 1 to 3 days. Total RNAs were extracted 
at each time point and taken for quantitative PCR for individual genes. The oligonucleotide primers used are 
summarised in Supplementary Table 1. Relative mRNA levels of the lipid-related molecules are presented as 
heat maps. (A) lipid-degrading enzymes, (B) lipid-biosynthetic enzymes, (C) ABC transporters, (D) P-type 
ATPases, (E) anoctamins and Xkr proteins.
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Figure 6. Role of LPEAT2 in PE biosynthesis and osteoclast formation. (A) Gene expression of Lpeat2 
during osteoclastogenesis. Osteoclast precursors (day 0) were cultured with M-CSF and RANKL for 1 to 3 
days and subjected to quantitative PCR analysis (n = 3). (B–I) shRNA-mediated knockdown of LPEAT2 in 
osteoclasts. Osteoclast precursors were infected with retrovirus expressing shRNA for LPEAT2 or control and 
then cultured with M-CSF and RANKL for 5 days. (B) Efficiency of shRNA-mediated knockdown was validated 
by quantitative PCR (n = 8). The cells infected with the shRNA-bearing retroviruses were stained for TRAP (C) 
and TRAP-positive multinucleated osteoclasts were counted (n = 8) (D). (E) The shRNA retrovirus-infected 
cells were subjected to MS analysis. Individual PC and PE species are quantified (n = 8). (F) Relative amounts 
(control versus LPEAT2 knockdown, with control as 1) of the individual phospholipid species quantified 
in (E) (n = 8). (G) The cells infected with the shRNA-bearing retrovirus were treated with SA-Bio-Ro and 
immunostained, and then the fluorescence intensity was quantified (n = 8). Representative fluorescence images 
are shown in (H). (I) Expressions of osteoclast-related genes in the shRNA retrovirus-infected cells (n = 12). 
Each value is the mean ± SE.
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Figure 7. Role of ABCB4 and ABCG1 in PE relocalisation and osteoclast formation. (A) Gene expressions 
of Abcb4 and Abcg1 during osteoclastogenesis as analysed by quantitative PCR (n = 3 to 5). (B–F) shRNA-
mediated knockdown of ABCB4 and ABCG1 in osteoclasts. Osteoclast precursors were infected with 
retroviruses expressing shRNAs for ABCB4 and ABCG1 (alone or in combination) or control and then cultured. 
(B) Efficiency of shRNA-mediated knockdown was validated by quantitative PCR (n = 10). (C) The shRNA 
retrovirus-infected cells were treated with SA-Bio-Ro, immunostained, and quantified the fluorescence intensity 
(n = 10 to 12). Representative fluorescence images are shown in (D). (E) The shRNA retrovirus-infected cells 
were stained for TRAP, and TRAP-positive multinucleated osteoclasts were counted (n = 12). (F) Expressions of 
osteoclast-related genes in the shRNA retrovirus-infected cells (n = 6). Each value is the mean ± SE.
www.nature.com/scientificreports/
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charged phospholipid is present predominantly in the inner leaflet of the plasma membrane and contributes to 
electrostatic association with cationic proteins beneath the membrane28. Because the asymmetrical distribution 
of phospholipids stabilises cell morphology, disruption of the asymmetrical topology changes the membrane 
curvature, thus altering the cell shape. For instance, PS is exposed on the surface of erythrocytes in humans with 
sickle cell disease29 and in mice deficient in ATP11C, a flippase, which results in erythrocytes having an abnormal 
shape30. In addition, PE is enriched in the cell surface of the cleavage furrow during cytokinesis14. Since filopodia 
are generally linked to cell motility and cell-cell interaction31, they undergo continuous alterations in morphology 
so as to elongate, retract, and turn in direction. Hence, it is reasonable to assume that membrane curvature of 
filopodia changes dynamically to ensure their flexibility.
We have shown in this study that osteoclast precursors elongate their filopodia, which form contacts with 
neighbouring precursors. In accordance with this, PE loses its asymmetric distribution, becoming exposed on 
the outer leaflet of filopodia. Furthermore, immobilisation of PE in mononucleated precursors inhibits cell-cell 
fusion, demonstrating that the mobility of PE in filopodia is pivotal for osteoclast fusion. Biophysical studies 
have shown that PE in the outer leaflet of the plasma membrane favours invagination for membrane budding 
because PE prefers to pack into concave structures32, that PE increases the formation of lipid buds and tubules in 
synthetic lipid vesicles33, and that PE promotes formation of the hemifusion intermediate during cell-cell fusion15. 
Therefore, disruption of the asymmetric distribution of PE in filopodia favours filopodium formation and cell-cell 
fusion. Accordingly, we conclude that the PE dynamics during osteoclastogenesis are essential for appropriate 
filopodium formation, followed by osteoclast fusion.
Although no unifying mechanisms underlying the various cell-cell fusion events have yet been proposed, 
it is likely that cell fusion is accompanied by redistribution of PE in the plasma membrane. Indeed, in fusing 
chick embryonic myoblasts, PE is concentrated in the outer leaflet of the plasma membrane34. Besides PE, PS is 
also exposed on the cell surface of myoblasts34, although the functional importance of PS exposure in myoblasts 
has been obscure. Since PS is not exposed on the cell surface during osteoclastogenesis in the present study, the 
contribution of PS to osteoclast fusion seems unlikely. Biophysically, the head group of PE is less hydrated, so 
that adjacent PE-rich lipid bilayers can easily interact with each other, whereas PS-rich bilayers repel each other 
because of their electrostatic and hydration properties35. PE facilitates membrane fusion much more efficiently 
than PC and PS in liposome-liposome and virus-liposome fusion models36,37. Given that PS exposed on apoptotic 
cells is recognised by macrophages as an “eat-me” signal27, it is conceivable that PE and PS on the cell surface may 
have general and distinct roles as mediators of cell fusion and apoptotic phagocytosis, respectively.
We demonstrate that the PE dynamics during osteoclastogenesis consist of at least two steps; increase in PE 
synthesis by LPEAT2 and translocation of PE by ABCB4 and ABCG1. LPEAT2 is a member of the LPLAT fam-
ily in the Lands’ cycle pathway23, and has been reported to produce PE in preference to other phospholipids 
in vitro24, although its physiological function is still largely unknown. LPEAT2-knockdown experiments revealed 
that this enzyme indeed preferentially generates PE to PC during osteoclastogenesis. To our knowledge, our study 
is the first to identify the role of LPEAT2 in PE biosynthesis in a physiologically relevant context ex vivo, and 
will be a foundation to find the physiological function(s) of this enzyme in vivo in the future study. It is unlikely 
that LPEAT1, another PE-biosynthetic enzyme in the Lands’ cycle38, is a major contributor to PE synthesis for 
osteoclast fusion, because its expression level is low and shows reciprocal correlation with osteoclastogenesis. 
Furthermore, none of the enzymes in other PE-biosynthetic pathways tested, including those in the PS decarbox-
ylation and the CDP-ethanolamine pathways9, affects osteoclast fusion and differentiation. Taken together, these 
results suggest that LPEAT2 plays a principal role in PE production during osteoclastogenesis and that the enrich-
ment of PE with polyunsaturated fatty acids (arachidonic acid and DHA) may contribute to increased membrane 
fluidity, leading to acceleration of filopodium formation.
In addition to the increased PE biosynthesis by LPEAT2, here we demonstrate that ABCB4 and ABCG1 are 
responsible for the outward translocation of PE during osteoclastogenesis. The ABC transporter superfamily 
consists of about 50 molecules, among which at least 10 members are known to translocate phospholipids from 
the inner to the outer leaflet of the plasma membrane39. ABCB4 transports PC, PE, SM and cholesterol in vitro25 
and is crucial for the efflux of cholesterol and phospholipids into bile in vivo39. The expression level of Abcb4 
is increased approximately 80-fold in differentiating osteoclasts, suggesting its functional linkage to osteoclas-
togenesis. Indeed, a partial reduction of PE exposure by shRNA-mediated knockdown of ABCB4 leads to more 
profound inhibition of osteoclast fusion. It has been reported that ABCB4-deficient mice exhibit reductions of 
both bone mineral content and bone density, which are ascribed to impairment of intestinal vitamin D absorption 
due to reduction of hepatic bile secretion40. The paucity of vitamin D in these mice is so severe that the loss of 
bone formation caused by vitamin D insufficiency may overcome the decrease in bone absorption resulting from 
impairment of osteoclast formation associated with ABCB4 deficiency. ABCG1, in cooperation with ABCA1, 
effluxes cholesterol and PC into high-density lipoproteins and also regulates lipid homeostasis in various cells25. 
Although ABCG1 can efflux PC, PS, SM, cholesterol and vitamin E25,41, it remains controversial whether this 
transporter mediates efflux of PE42. Our present findings may represent the first evidence that ABCG1 transports 
PE to facilitate cell fusion in cooperation with ABCB4. It should be noted that inhibition of cholesterol efflux from 
late endosomes blocks osteoclast formation43, raising the possibility that the suppression of osteoclastogenesis by 
ABCB4 or ABCG1 knockdown is caused by the reduction of cholesterol efflux rather than or in addition to the 
impairment of PE exposure. Nevertheless, our results that osteoclast fusion is inhibited by immobilisation of cell 
surface PE with SA-Bio-Ro treatment, which does not affect cholesterol distribution, and that PE exposure is also 
reduced by LPEAT2 knockdown, resulting in inhibition of osteoclast formation, imply the importance of cell 
surface PE for osteoclast fusion.
In conclusion, our results highlight that rearrangement of PE in the plasma membrane is essential for osteo-
clast fusion. An increase in PE synthesis by LPEAT2 and exposure of PE on the outer leaflet by the phospholipid 
floppases ABCB4 and ABCG1 are required for adequate filopodium formation and function, and thereby cell-cell 
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fusion, in osteoclasts. Although in vivo studies to expand our findings will be needed, our present results none-
theless provide new insight into osteoclast biology.
Methods
Cell culture. C57BL/6 mice were purchased from Charles River Laboratories Japan (Yokohama). Bone 
marrow cells were isolated from C57BL/6 mice (4–7 weeks old, male) and cultured in α -minimum essential 
medium (α -MEM) containing 10% (v/v) FBS, 100 ng/ml M-CSF (Kyowa Hakko Kogyo) and 1 ng/ml TGF-β (R 
& D Systems) in 100-mm culture dishes. After 3 days of culture, floating cells were removed and attached cells 
were used as osteoclast precursors. To generate osteoclasts, the osteoclast precursors were cultured for 3 days in 
α -MEM containing 10% FBS, 150 ng/ml soluble RANKL (Oriental Yeast) and 50 ng/ml M-CSF.
TRAP staining. Osteoclast differentiation was assessed by TRAP staining as described previously44. Briefly, 
cultured cells were fixed with 10% (v/v) formalin in PBS followed by ethanol/acetone (1/1, v/v), and stained for 
TRAP with 0.1 mg/ml naphthol AS-MX phosphate (Sigma) and 0.6 mg/ml fast red violet LB salt (Sigma) in 0.1 M 
sodium acetate buffer, pH 5.0, containing 50 mM sodium tartrate. The TRAP-positive cells were photographed 
with a BZ-8000 digital microscope (Keyence), and counted manually. In some experiments, TRAP activity was 
quantified as follows. Cells in 96-well plates were fixed and incubated for 5 min in 0.1 ml of 10 mM p-nitrophenyl 
phosphate (Sigma) in 0.1 M sodium acetate buffer, pH 5.0, containing 50 mM sodium tartrate. After incuba-
tion, the solution was transferred to a tube containing 0.1 ml of 0.1 N NaOH, and the absorbance at 405 nm was 
determined.
Phospholipid composition analysis. Phospholipids were extracted from cells by the method of Bligh and 
Dyer45 and separated by two-dimensional thin layer chromatography on silica plates. The solvent systems used for 
chromatography were chloroform/methanol/acetic acid, 65:25:10 (v/v/v) in the first dimension and chloroform/
methanol/formic acid, 65:25:10 (v/v/v) in the second dimension. Lipids were visualised with iodine vapour and 
identified by comparing their positions with those of authentic standard phospholipids. The individual spots were 
scraped off and the lipid phosphorus was quantified as described by Gerlach and Deuticke46.
MS analysis. MS analysis was performed using a 4000Q-TRAP quadrupole-linear ion trap hybrid mass spec-
trometer (AB Sciex) with a NexeraX2 liquid chromatography system (Shimazu). The samples were separated by 
a step gradient with mobile phase A (acetonitrile/methanol/water, 1:1:1 (v/v/v), containing 5 μ M phosphoric acid 
and 1 mM ammonium formate) and mobile phase B (2-propanol containing 5 μ M phosphoric acid and 1 mM 
ammonium formate) at a flow rate of 80 μ l/min at 50 °C. The detection of each lipid was performed by electros-
pray mass spectrometry and multiple reaction monitoring. PC and PE with C14:0-C14:0 (Avanti Polar Lipids) 
were used as internal standards for quantification.
Fluorescence microscopy. Streptavidin (Jackson) was conjugated with biotinylated Ro09–0198 (provided 
by Dr. M. Umeda, Kyoto Univ., Japan) and separated from free biotinylated Ro09–0198 using a Sephadex G-25 gel 
filtration column (GE Healthcare). For staining of cell surface PE, cells were incubated with 50 μ g/ml SA-Bio-Ro 
for 30 min in α -MEM containing 0.2% (w/v) fatty acid-free bovine serum albumin (BSA) (Sigma). The cells were 
washed with 20 mM HEPES, pH 7.4, 115 mM NaCl, 5.4 mM KCl, 2.2 mM CaCl2, 0.8 mM MgCl2 and 13.8 mM 
glucose, and then fixed with 4% (w/v) paraformaldehyde in PBS for 30 min, followed by a 5-min permeabilisation 
with 0.1% (v/v) Triton X-100 in PBS. Immunostaining was performed with a FITC-conjugated anti-streptavidin 
antibody (Vector Laboratories). F-actin was stained using Alexa Fluor 594-conjugated phalloidin (Molecular 
Probes). PS on the cell surface was detected with an annexin V-Cy5 apoptosis detection kit (BioVision) in accord-
ance with the manufacturer’s protocol. Fluorescence microscopy was performed using a DSU-IX81 microscope 
(Olympus). The images were photographed with a C10600 digital camera (Hamamatsu Photonics). In some 
experiments, immunofluorescence intensity of cells cultured in 96-well plates was quantified with an ImageXpress 
Micro XL HCS (Molecular Devices) and MetaXpress Image Analysis software (Molecular Devices).
Cell fusion arrest by SA-Bio-Ro. Osteoclast precursors were cultured for 2 days in α -MEM containing 
10% FBS, 150 ng/ml soluble RANKL and 50 ng/ml M-CSF. The cells were then incubated with various concentra-
tions of SA-Bio-Ro for 1 h in α -MEM containing 0.2% fatty acid free BSA, and washed with α -MEM containing 
10% dialysed FBS. The cells were cultured for a further day in α -MEM containing 10% dialysed FBS and stained 
for TRAP as described above.
Retrovirus production and infection. To construct shRNA-expressing vectors, shRNA oligonu-
cleotide targeting sequences were inserted into a pSIREN-RetroQ-DsRed expressing vector (Clontech). 
The targeting sequences used were as follows: ABCA2, 5’-GCTGGATGCCCAGAAACTTCT-3’; ABCB4, 
5’-GAGCTAGCTGCATATGCAA-3’; ABCG1, 5’-GGATCTCTGGGAAATTCAACA-3’; AGPAT4, 
5’-GGGTAAGATGACTAAAT TA-3’ ;  Ano6,  5’-GCGAGAAGAT TGGAATCTACT-3’ ;  ATP8B4, 
5’-CTCGAACTCCAGAGACAATTA-3’; LPEAT2, 5’-CGCGTGGCTCCAAGTAGCA-3’; PCYT2, 
5’-GCTATGACATGGTGCATTATG-3’; PS decarboxylase, 5’-GTACAGGGAACGGAAGCTT-3’. A negative 
control shRNA-expressing vector was constructed in accordance with the manufacturer’s protocol (Clontech). 
Recombinant retroviruses were produced by co-transfecting the pSIREN-RetroQ-DsRed vectors together with 
an envelope expression vector, pVSV-G (Clontech), into GP2–293 pantropic packaging cells (Clontech) using 
Lipofectamine LTX (Invitrogen). The culture medium was replaced with fresh α -MEM containing 10% FBS for 
8 h following transfection. The viral supernatants were harvested at 2 days after transfection and filtered with a 
0.45-μ m filter. For infection, osteoclast precursors (1.4 × 104 cells) were plated on a 96-well plate. On the follow-
ing day, the medium was replaced with 250 μ l of the viral supernatant containing 5 μ g/ml polybrene (Nacalai 
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Tesque) and 100 ng/ml M-CSF. After 8 h, the viral supernatant was removed, and the cells were cultured in growth 
medium containing RANKL and M-CSF for subsequent analysis.
Quantitative PCR analysis. Total RNA was extracted from cells or tissues using TRIsol reagent 
(Invitrogen), and reverse-transcribed using PrimeScript RT Master Mix (Takara Bio) in accordance with the 
manufacturer’s protocol. Quantitative PCR analysis was performed with a LightCycler 480 (Roche) using SYBR 
Premix Ex Taq II (Takara Bio). Oligonucleotide primers used in quantitative PCR analysis were designed using 
ProbeFinder software (Roche). In some experiments, quantitative PCR analysis was performed with a TaqMan 
Gene expression system and TaqMan probes (Applied Bioscience). The primers and probes used are listed in 
Supplementary Table 1.
Statistics. Data were expressed as the mean ± SE. Statistical significance was assessed using unpaired 
Student’s t test (in the figures, statistical significance is denoted as follows: *p < 0.05, **p < 0.01, and ***p < 0.001).
Study approval. Procedures carried out using mice were approved by the Institutional Animal Care 
Committee of Tokyo Metropolitan Institute of Medical Science, in accordance with the Standards Relating to the 
Care and Management of Experimental Animals in Japan.
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